343 related articles for article (PubMed ID: 11475792)
1. [Recent studies on the pathogenesis of cholelithiasis: the role of the gallbladder epithelium].
Corradini SG; Liguori F
Recenti Prog Med; 2001; 92(7-8):471-6. PubMed ID: 11475792
[TBL] [Abstract][Full Text] [Related]
2. Impaired human gallbladder lipid absorption in cholesterol gallstone disease and its effect on cholesterol solubility in bile.
Corradini SG; Elisei W; Giovannelli L; Ripani C; Della Guardia P; Corsi A; Cantafora A; Capocaccia L; Ziparo V; Stipa V; Chirletti P; Caronna R; Lomanto D; Attili AF
Gastroenterology; 2000 May; 118(5):912-20. PubMed ID: 10784590
[TBL] [Abstract][Full Text] [Related]
3. Human gallbladder mucosal function: effects on intraluminal fluid and lipid composition in health and disease.
Ginanni Corradini S; Yamashita G; Nuutinen H; Chernosky A; Williams C; Hays L; Shiffman ML; Walsh RM; Svanvik J; Della Guardia P; Capocaccia L; Holzbach RT
Dig Dis Sci; 1998 Feb; 43(2):335-43. PubMed ID: 9512127
[TBL] [Abstract][Full Text] [Related]
4. [Role of biliary proteins in pathogenesis of cholesterol gallstones].
Secknus R; Holzbach RT
Z Gastroenterol; 1997 Jan; 35(1):41-6. PubMed ID: 9123957
[TBL] [Abstract][Full Text] [Related]
5. Role of gallbladder mucin in pathophysiology of gallstones.
LaMont JT; Smith BF; Moore JR
Hepatology; 1984; 4(5 Suppl):51S-56S. PubMed ID: 6546237
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of gallbladder cholecystokinin: a receptor in prairie dogs fed a high-cholesterol diet and its dissociation with decreased contractility in response to cholecystokinin.
Kano M; Shoda J; Satoh S; Kobayashi M; Matsuzaki Y; Abei M; Tanaka N
J Lab Clin Med; 2002 May; 139(5):285-94. PubMed ID: 12032489
[TBL] [Abstract][Full Text] [Related]
7. Effects of cholesterol gallstone induction on gallbladder function and bile salt pool size in the prairie dog model.
Meyer PD; Den Besten L; Gurll NJ
Surgery; 1978 May; 83(5):599-604. PubMed ID: 644451
[TBL] [Abstract][Full Text] [Related]
8. Gallbladder mucin, arachidonic acid, and bile lipids in patients who develop gallstones during weight reduction.
Shiffman ML; Shamburek RD; Schwartz CC; Sugerman HJ; Kellum JM; Moore EW
Gastroenterology; 1993 Oct; 105(4):1200-8. PubMed ID: 8405867
[TBL] [Abstract][Full Text] [Related]
9. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
10. [Pathophysiology of gallstone formation].
Wermke W; Borges AC
Ther Umsch; 1993 Aug; 50(8):541-6. PubMed ID: 8211853
[TBL] [Abstract][Full Text] [Related]
11. Gallbladder mucin as a pronucleating agent for cholesterol monohydrate crystals in bile.
Smith BF
Hepatology; 1990 Sep; 12(3 Pt 2):183S-186S; discussion 186S-188S. PubMed ID: 2210647
[TBL] [Abstract][Full Text] [Related]
12. Mucin genes in gallstone disease.
Chuang SC; Hsi E; Lee KT
Clin Chim Acta; 2012 Oct; 413(19-20):1466-71. PubMed ID: 22705400
[TBL] [Abstract][Full Text] [Related]
13. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.
Amigo L; Quiñones V; Mardones P; Zanlungo S; Miquel JF; Nervi F; Rigotti A
Gastroenterology; 2000 Apr; 118(4):772-9. PubMed ID: 10734029
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin in human gallbladder bile: cholesterol pronucleating and/or mucin "link" protein?
Miquel JF; Von Ritter C; Del Pozo R; Lange V; Jüngst D; Paumgartner G
Am J Physiol; 1994 Sep; 267(3 Pt 1):G393-400. PubMed ID: 7943236
[TBL] [Abstract][Full Text] [Related]
15. The cholecystokinin-1 receptor antagonist devazepide increases cholesterol cholelithogenesis in mice.
Wang HH; Portincasa P; Wang DQ
Eur J Clin Invest; 2016 Feb; 46(2):158-69. PubMed ID: 26683129
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients.
Jüngst C; Sreejayan N; Eder MI; von Stillfried N; Zündt B; Spelsberg FW; Kullak-Ublick GA; Jüngst D; von Ritter C
Eur J Clin Invest; 2007 Sep; 37(9):731-6. PubMed ID: 17696963
[TBL] [Abstract][Full Text] [Related]
17. Gallbladder prostaglandins and lysophospholipids as mediators of mucin secretion during cholelithiasis.
LaMorte WW; LaMont JT; Hale W; Booker ML; Scott TE; Turner B
Am J Physiol; 1986 Nov; 251(5 Pt 1):G701-9. PubMed ID: 3777174
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease.
Groen AK; Noordam C; Drapers JA; Egbers P; Jansen PL; Tytgat GN
Hepatology; 1990 Apr; 11(4):525-33. PubMed ID: 2328950
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol gallstone pathogenesis: a study of potential nucleating agents for cholesterol crystal formation in bile.
Whiting MJ; Watts JM
Clin Sci (Lond); 1985 May; 68(5):589-96. PubMed ID: 3884240
[TBL] [Abstract][Full Text] [Related]
20. Ground squirrel model for cholelithiasis: role of epithelial glycoproteins.
MacPherson BR; Pemsingh RS
Microsc Res Tech; 1997 Oct; 39(1):39-55. PubMed ID: 9329018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
